Sources Sought Notice - Cost-Per-Test (CPT) Agreement or Reagent Rental Agreement to include reagents, molecular PCR instrument/equipment, consumables, maintenance support and instrument warranties at BAMC.
ID: 12272024Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M USA HCAJBSA FT SAM HOUSTON, TX, 78234-4504, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/cf7aa66bd05e4f258f3469c36ba9f2c3/view
Timeline
    Description

    The Department of Defense, through the Medical Readiness Contracting Office West (MRCO), is seeking potential sources for a Cost-Per-Test (CPT) Agreement or Reagent Rental Agreement to support molecular genetic and infectious disease testing at the Brooke Army Medical Center (BAMC) in Fort Cavazos, Texas. The procurement includes the provision of molecular PCR instruments, reagents, consumables, maintenance support, and instrument warranties, with a base performance period from October 1, 2025, to September 30, 2030. This initiative is critical for enhancing the laboratory's capabilities in conducting various genetic tests, including those for Celiac Disease, Alzheimer’s Disease, and a comprehensive Dermatomycosis Panel, which are essential for informed health assessments and treatment decisions. Interested parties are encouraged to submit their capability statements and relevant information to the primary contact, Medina L. Woodson, at medina.l.woodson.civ@health.mil, by the specified deadlines, as this notice is solely for information and planning purposes and does not constitute a solicitation.

    Point(s) of Contact
    Medina L. Woodson
    (210) 539-8525
    (210) 221-3446
    medina.l.woodson.civ@health.mil
    Salameya Paulouskaya
    (210) 539-8656
    (210) 221-3446
    salameya.paulouskaya2.civ@health.mil
    Files
    Title
    Posted
    TABLE 1 - WORKLOAD DATA - Molecular PCR Testing.docx
    The document outlines various genetic and medical tests, specifically detailing their types and corresponding point values for evaluation. The tests listed include Celiac/HLA-DQ8-h, Alzheimer’s/APOE Direct, Haemochromatosis 4SNP+Direct, and a Dermatomycosis Panel, each assigned a value of 120 points. This structure indicates a standardized assessment metric for these tests within the context of federal and state health assessments or grants. The focus suggests an initiative to promote genetic testing as a means to better understand health conditions and inform treatment decisions. Overall, the document serves to facilitate understanding and comparison of these specific medical tests, which may relate to broader public health initiatives or research under government funding avenues.
    Similar Opportunities
    6550--Lab Testing Services - (HIV/HCV/HPV/On)
    Buyer not available
    The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
    Microbial Testing Supplies - Bridge Contract
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    6640--AutoMicrobiological Blood Culture Testing/Systems (CPT) VISN 15
    Buyer not available
    The Department of Veterans Affairs is seeking qualified contractors to provide Cost Per Test (CPT) for Automated Microbiological Blood Culture Testing/Systems across multiple facilities under VISN 15. The procurement aims to gather information from Service-Disabled Veteran Owned Small Businesses (SDVOSB), Veteran Owned Small Businesses (VOSB), and other small businesses capable of supplying testing equipment, reagents, maintenance, and personnel training, all compliant with FDA standards and the Clinical Laboratory Improvement Act. This initiative is crucial for enhancing healthcare services for veterans, ensuring reliable and efficient testing processes. Interested parties must respond by March 7, 2025, and are required to be registered in the System for Award Management (SAM); for further inquiries, contact Contract Specialist Maria Riza Owen at maria.owen2@va.gov or call 913-946-1122.
    6550--VISN 19 Compatible Cepheid Reagents and Consumables
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking potential suppliers for compatible Cepheid reagents and consumables through a Sources Sought Notice issued by the Network Contracting Office 19. The procurement aims to identify suppliers of molecular diagnostic test kits for various pathogens, including Methicillin-Resistant Staphylococcus aureus, Norovirus, and Covid, to enhance the diagnostic capabilities of the VA's Pathology and Laboratory Services across multiple clinical laboratory locations. This initiative underscores the VA's commitment to improving healthcare for veterans while adhering to federal procurement standards. Interested vendors are encouraged to submit their capabilities, business size status, and compliance details by March 13, 2025, at 9 AM MT, with inquiries directed to Contract Specialist Tania Urenda at tania.urenda@va.gov or by phone at 303-712-5730.
    6640--FY25 Q3 Micro Molecular Testing (VA-25-00029953)
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of Micro Molecular Testing supplies for the West Palm Beach VA Hospital, under Solicitation No. 36C24825Q0395. The procurement includes various laboratory items and equipment, such as testing kits and the leasing of laboratory instruments, with a requirement for vendors to be Authorized Distributors and provide proof of their status. This initiative is part of the VA's commitment to enhancing its laboratory capabilities to effectively serve veterans. Interested vendors must submit their quotations via email by March 12, 2025, at 2:00 PM Eastern Time, and are encouraged to stay updated on any changes to the solicitation through the Beta-Sam website. For further inquiries, vendors can contact Contract Officer David Henry at David.Henry3@va.gov or by phone at 561-631-3352.
    Q301-- Five (5) Full-Time Equivalent Certified Medical Technologists
    Buyer not available
    The Department of Veterans Affairs is seeking to procure the services of five full-time certified Medical Technologists to support the Public Health National Program Office. These professionals will be responsible for performing high-complexity molecular laboratory testing and laboratory information management services, which are critical for the nation's biodefense strategy and public health preparedness, particularly in diagnosing emerging pathogens and high-consequence infections. Interested vendors must respond with their company details and capabilities by March 13, 2025, with a preference for submissions from service-disabled veteran-owned and veteran-owned small businesses. For further inquiries, potential respondents can contact Contracting Officer Larry Facio at Larry.Facio@va.gov or by phone at 916-923-4553.
    vitro diagnostic substances, reagents, test kits and sets
    Buyer not available
    The Department of Defense, through the Naval Medical Research Center, is seeking proposals for a Women-Owned Small Business (WOSB) contract focused on procuring in-vitro diagnostic substances, reagents, and test kits, specifically targeting Biofire Defense products. This procurement is critical for developing reagents used in biological defense against warfare agents, with a total contract value of $64,978.00 for the unique 10x Buffer with BSA 50mM Mg2Cl2, which is essential for operational effectiveness. Interested vendors must submit their offers by March 8, 2025, at 2:00 PM local time, and can direct inquiries to Deborah Sharpe at deborah.m.sharpe2.civ@health.mil or 301-319-9948.
    Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC), Germany
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking proposals for Clinical Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC) in Germany. The contract, identified by Solicitation Number W9114F25QA019, will cover a range of laboratory tests required from May 1, 2025, through April 30, 2026, with a focus on compliance with College of American Pathologists (CAP) standards and timely reporting of results within 72 hours. This procurement is crucial for maintaining healthcare service standards for military personnel, ensuring accurate and efficient laboratory testing. Interested contractors must submit their proposals, including pricing details and compliance with federal regulations, to the primary contact, Henning Mayer-Goldstein, at henningfalk.mayer-goldstein.ln@health.mil by the specified deadlines.
    Request for Information (RFI) for Device and Maintenance Services for medical point-of-care molecular disease analyzer.
    Buyer not available
    The Department of Homeland Security, specifically the U.S. Coast Guard (USCG), is issuing a Request for Information (RFI) to explore the market for medical point-of-care molecular disease analyzers, with the intent to replace its aging Cepheid GeneXpert systems. The USCG aims to procure approximately 55 new devices that can test for multiple diseases, including SARS-CoV-2, Influenza A and B, and various bacterial infections, emphasizing the need for FDA approval, high specificity and sensitivity, rapid turnaround times within 60 minutes, and compatibility with electronic health records. This initiative is crucial for enhancing the USCG's medical capabilities and ensuring timely disease detection among personnel. Interested vendors are encouraged to submit their responses by March 25, 2025, and can direct inquiries to Jamison Harned at jamison.w.harned@uscg.mil or by phone at 571-613-5151.
    Monoclonal Antibodies and Viral Recombinant Antigens
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking suppliers for monoclonal antibodies and viral recombinant antigens, as outlined in a Special Notice. This procurement aims to acquire in vitro diagnostic substances, reagents, test kits, and sets, which are critical for various medical and research applications within the military health system. The place of performance for this contract will be in Maryland, United States, and interested vendors can reach out to Shelley Wallace at shelley.a.wallace2.civ@health.mil or Tonya Kreps at tonya.r.kreps.civ@health.mil for further information. The notice does not specify a funding amount or key deadlines, but interested parties are encouraged to inquire for additional details.